TY - JOUR
T1 - HFA of the ESC Position paper on the management of LVAD supported patients for the non LVAD specialist healthcare provider Part 1
T2 - Introduction and at the non-hospital settings in the community
AU - Ben Avraham, Binyamin
AU - Crespo-Leiro, Marisa Generosa
AU - Filippatos, Gerasimos
AU - Gotsman, Israel
AU - Seferovic, Petar
AU - Hasin, Tal
AU - Potena, Luciano
AU - Milicic, Davor
AU - Coats, Andrew J.S.
AU - Rosano, Giuseppe
AU - Ruschitzka, Frank
AU - Metra, Marco
AU - Anker, Stefan
AU - Altenberger, Johann
AU - Adamopoulos, Stamatis
AU - Barac, Yaron D.
AU - Chioncel, Ovidiu
AU - De Jonge, Nicolaas
AU - Elliston, Jeremy
AU - Frigeiro, Maria
AU - Goncalvesova, Eva
AU - Grupper, Avishay
AU - Hamdan, Righab
AU - Hammer, Yoav
AU - Hill, Loreena
AU - Itzhaki Ben Zadok, Osnat
AU - Abuhazira, Miriam
AU - Lavee, Jacob
AU - Mullens, Wilfried
AU - Nalbantgil, Sanemn
AU - Piepoli, Massimo F.
AU - Ponikowski, Piotr
AU - Ristic, Arsen
AU - Ruhparwar, Arjang
AU - Shaul, Aviv
AU - Tops, Laurens F.
AU - Tsui, Steven
AU - Winnik, Stephan
AU - Jaarsma, Tiny
AU - Gustafsson, Finn
AU - Ben Gal, Tuvia
N1 - Publisher Copyright:
© 2021 The Authors. ESC Heart Failure published by John Wiley & Sons Ltd on behalf of European Society of Cardiology.
PY - 2021/12
Y1 - 2021/12
N2 - The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.
AB - The accepted use of left ventricular assist device (LVAD) technology as a good alternative for the treatment of patients with advanced heart failure together with the improved survival of the LVAD-supported patients on the device and the scarcity of donor hearts has significantly increased the population of LVAD-supported patients. The expected and non-expected device-related and patient–device interaction complications impose a significant burden on the medical system exceeding the capacity of the LVAD implanting centres. The ageing of the LVAD-supported patients, mainly those supported with the ‘destination therapy’ indication, increases the risk for those patients to experience comorbidities common in the older population. The probability of an LVAD-supported patient presenting with medical emergency to a local emergency department, internal, or surgical ward of a non-LVAD implanting centre is increasing. The purpose of this trilogy is to supply the immediate tools needed by the non-LVAD specialized physician: ambulance clinicians, emergency ward physicians, general cardiologists, internists, anaesthesiologists, and surgeons, to comply with the medical needs of this fast-growing population of LVAD-supported patients. The different issues discussed will follow the patient's pathway from the ambulance to the emergency department and from the emergency department to the internal or surgical wards and eventually to the discharge home from the hospital back to the general practitioner. In this first part of the trilogy on the management of LVAD-supported patients for the non-LVAD specialist healthcare provider, after the introduction on the assist devices technology in general, definitions and structured approach to the assessment of the LVAD-supported patient in the ambulance and emergency department is presented including cardiopulmonary resuscitation for LVAD-supported patients.
UR - http://www.scopus.com/inward/record.url?scp=85114895413&partnerID=8YFLogxK
U2 - 10.1002/ehf2.13588
DO - 10.1002/ehf2.13588
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 34519177
AN - SCOPUS:85114895413
SN - 2055-5822
VL - 8
SP - 4394
EP - 4408
JO - ESC heart failure
JF - ESC heart failure
IS - 6
ER -